FDA Inspection 1015280 — Lomapharm Rudolf Lohmann GmbH KG

Lomapharm Rudolf Lohmann GmbH KG — FEI 1000634798

The FDA completed an inspection of Lomapharm Rudolf Lohmann GmbH KG on May 4, 2017 in Emmerthal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 4, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Emmerthal (Germany)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.